Applied Clinical Trials-12-01-2021

Stakeholders from across the industry must discuss ownership to ensure effective implementation.

Roadmap of twists and turns that lie ahead following most recent draft issued in September.

Lessons learned from FDA’s current process and proposed alternative review strategies.

New benchmarks uncover a maturing and globally-shifting market.

Darcy Flora, PhD, chief research officer of GRYT Health, a digital oncology company, discusses her career, the company, and drug development.

Increased public engagement leads recent change in EMA profile.

Lessons learned from COVID-19 vaccine development.

What does 2022 hold for industry?

Click the title above for a link to open the Applied Clinical Trials December 2021 issue in an interactive PDF format.

Improving receptivity and response to the evolving nature of clinical trial patient oversight.

Implementing new strategies with the use of patient-reported outcomes.

Higher costs headline list of new challenges faced by CROs and sponsors.